Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273-281

Mohammad Umar Farooq; Koroush Khalighi

doi:10.3390/jcdd3010004

Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273-281

J Cardiovasc Dev Dis. 2016 Jan 26;3(1):4. doi: 10.3390/jcdd3010004.

Authors

Mohammad Umar Farooq¹, Koroush Khalighi²

Affiliations

¹ Department of Cardiovascular Disease, Easton Hospital Easton, PA Clinical Professor of Medicine, Drexel University, School of Medicine Easton Cardiovascular Associates 2001 Fairview Ave, Easton, PA 18042, USA. Mohammad_Farooq@chs.net.
² Department of Medicine, Easton Hospital, 250 South 21 street, Easton, PA 18042, USA. koroushkhalighi@gmail.com.

Abstract

We appreciate the thorough response given by Ponagmi et al. [1], who rightly point out that the pathophysiology and modifiable risk factors of Takotsubo Cardiomyopathy (TC) have yet to be unequivocally established. [...].